Hans-Joerg Burger

951 total citations
14 papers, 789 citations indexed

About

Hans-Joerg Burger is a scholar working on Rheumatology, Molecular Biology and Surgery. According to data from OpenAlex, Hans-Joerg Burger has authored 14 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Rheumatology, 7 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Hans-Joerg Burger's work include Glycogen Storage Diseases and Myoclonus (13 papers), Metabolism and Genetic Disorders (4 papers) and Pancreatic function and diabetes (4 papers). Hans-Joerg Burger is often cited by papers focused on Glycogen Storage Diseases and Myoclonus (13 papers), Metabolism and Genetic Disorders (4 papers) and Pancreatic function and diabetes (4 papers). Hans-Joerg Burger collaborates with scholars based in United States, Netherlands and Germany. Hans-Joerg Burger's co-authors include Andreas W. Herling, Horst Hemmerle, Gerrit Alexander Schubert, Peter Below, Peter W. Schindler, William J. Arion, Wesley K. Canfield, Alfred J. Meijer, Johannes A. Romijn and Folkert Kuipers and has published in prestigious journals such as Journal of Biological Chemistry, Diabetes and Biochemical Journal.

In The Last Decade

Hans-Joerg Burger

14 papers receiving 737 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans-Joerg Burger United States 11 279 198 188 157 106 14 789
Peter W. Schindler Germany 9 226 0.8× 195 1.0× 78 0.4× 105 0.7× 119 1.1× 20 684
P. Mark Stavro Canada 11 379 1.4× 97 0.5× 25 0.1× 101 0.6× 77 0.7× 14 770
Hae‐Gon Chung South Korea 19 438 1.6× 163 0.8× 19 0.1× 121 0.8× 54 0.5× 44 902
Mohamed B. Ashour Egypt 12 241 0.9× 86 0.4× 22 0.1× 312 2.0× 89 0.8× 16 836
Raju Padiya India 12 240 0.9× 72 0.4× 14 0.1× 197 1.3× 133 1.3× 21 763
Eman A. Abdelghffar Egypt 15 165 0.6× 69 0.3× 28 0.1× 83 0.5× 32 0.3× 27 672
Putcharawipa Maneesai Thailand 19 230 0.8× 100 0.5× 11 0.1× 163 1.0× 96 0.9× 50 796
Jingda Li China 12 286 1.0× 80 0.4× 14 0.1× 109 0.7× 65 0.6× 27 688
Mitsuru Kimira Japan 9 301 1.1× 197 1.0× 19 0.1× 248 1.6× 109 1.0× 18 1.3k
Antonella Brusamolino Italy 15 184 0.7× 33 0.2× 27 0.1× 77 0.5× 77 0.7× 20 850

Countries citing papers authored by Hans-Joerg Burger

Since Specialization
Citations

This map shows the geographic impact of Hans-Joerg Burger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans-Joerg Burger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans-Joerg Burger more than expected).

Fields of papers citing papers by Hans-Joerg Burger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans-Joerg Burger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans-Joerg Burger. The network helps show where Hans-Joerg Burger may publish in the future.

Co-authorship network of co-authors of Hans-Joerg Burger

This figure shows the co-authorship network connecting the top 25 collaborators of Hans-Joerg Burger. A scholar is included among the top collaborators of Hans-Joerg Burger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans-Joerg Burger. Hans-Joerg Burger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Herling, Andreas W., Dietmar Schwab, Hans-Joerg Burger, et al.. (2002). Prolonged blood glucose reduction in mrp-2 deficient rats (GY/TR−) by the glucose-6-phosphate translocase inhibitor S 3025. Biochimica et Biophysica Acta (BBA) - General Subjects. 1569(1-3). 105–110. 10 indexed citations
2.
Dubbelhuis, Peter F., Edward F. C. Blommaart, George M. VAN WOERKOM, et al.. (2002). Inhibition of autophagic proteolysis by inhibitors of phosphoinositide 3-kinase can interfere with the regulation of glycogen synthesis in isolated hepatocytes. Biochemical Journal. 368(3). 827–833. 3 indexed citations
3.
Bandsma, Robert, Coen Wiegman, Andreas W. Herling, et al.. (2001). Acute Inhibition of Glucose-6-Phosphate Translocator Activity Leads to Increased De Novo Lipogenesis and Development of Hepatic Steatosis Without Affecting VLDL Production in Rats. Diabetes. 50(11). 2591–2597. 58 indexed citations
4.
Kuipers, Folkert, Hans P. Sauerwein, Johannes A. Romijn, et al.. (2001). Fatty acid and amino acid modulation of glucose cycling in isolated rat hepatocytes. Biochemical Journal. 358(3). 665–665. 26 indexed citations
5.
Kuipers, Folkert, Hans P. Sauerwein, Johannes A. Romijn, et al.. (2001). Fatty acid and amino acid modulation of glucose cycling in isolated rat hepatocytes. Biochemical Journal. 358(3). 665–671. 18 indexed citations
6.
Herling, Andreas W., et al.. (2000). Upregulation of Hepatic Glucose 6-Phosphatase Gene Expression in Rats Treated with an Inhibitor of Glucose-6-phosphate Translocase. Archives of Biochemistry and Biophysics. 373(2). 418–428. 25 indexed citations
7.
Burger, Hans-Joerg, et al.. (1999). Identification of protein components of the microsomal glucose 6-phosphate transporter by photoaffinity labelling. Biochemical Journal. 339(3). 629–629. 3 indexed citations
8.
Herling, Andreas W., et al.. (1999). Alterations of carbohydrate and lipid intermediary metabolism during inhibition of glucose-6-phosphatase in rats. European Journal of Pharmacology. 386(1). 75–82. 49 indexed citations
9.
Kramer, Werner, Hans-Joerg Burger, William J. Arion, et al.. (1999). Identification of protein components of the microsomal glucose 6-phosphate transporter by photoaffinity labelling. Biochemical Journal. 339(3). 629–638. 8 indexed citations
10.
Arion, William J., Wesley K. Canfield, Hans-Joerg Burger, et al.. (1998). Chlorogenic Acid Analogue S 3483: A Potent Competitive Inhibitor of the Hepatic and Renal Glucose-6-Phosphatase Systems. Archives of Biochemistry and Biophysics. 351(2). 279–285. 60 indexed citations
11.
Arion, William J., Wesley K. Canfield, Evelyn Callaway, et al.. (1998). Direct Evidence for the Involvement of Two Glucose 6-Phosphate-binding Sites in the Glucose-6-phosphatase Activity of Intact Liver Microsomes. Journal of Biological Chemistry. 273(11). 6223–6227. 30 indexed citations
12.
Arion, William J., Wesley K. Canfield, Peter W. Schindler, et al.. (1997). Chlorogenic Acid and Hydroxynitrobenzaldehyde: New Inhibitors of Hepatic Glucose 6-Phosphatase. Archives of Biochemistry and Biophysics. 339(2). 315–322. 214 indexed citations
13.
Hemmerle, Horst, Hans-Joerg Burger, Peter Below, et al.. (1997). Chlorogenic Acid and Synthetic Chlorogenic Acid Derivatives:  Novel Inhibitors of Hepatic Glucose-6-phosphate Translocase. Journal of Medicinal Chemistry. 40(2). 137–145. 252 indexed citations
14.
Burger, Hans-Joerg, Erin G. Schuetz, John D. Schuetz, & Philip S. Guzelian. (1990). Divergent effects of cycloheximide on the induction of Class II and Class III cytochrome P450 mRNAs in cultures of adult rat hepatocytes. Archives of Biochemistry and Biophysics. 281(2). 204–211. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026